SCHEMBL25281145

SCHEMBL25281145

N#Cc1cncc2c1CNCC2

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 9/20 0.46
DRD2 P14416 2/20 0.42
DRD3 P35462 2/20 0.42
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR2B P41595 1/20 0.40
CYP11B2 P19099 1/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
CD44 P16070 1/20 0.34
MAOB P27338 1/20 0.34
PRCP P42785 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30183105 1.00 PNMT (0.46) PNMTDRD2DRD3HTR2AHTR2C
Hydrochloric Acid SCHEMBL25281366 0.98 PNMT (0.45) PNMTDRD2DRD3HTR2AHTR2C
Hydrochloric Acid SCHEMBL31186539 0.98 PNMT (0.45) PNMTDRD2DRD3HTR2AHTR2C
Trifluoroacetic Acid SCHEMBL31186449 0.86 KDM1A (0.41) PNMTDRD2DRD3
SCHEMBL31310249 0.83 PNMT (0.33) PNMTDRD2DRD3CYP11B2
SCHEMBL19711547 0.74 CHRNB2 (0.41) PNMTCHRNB2CHRNA4ADRA2AADRA2B
SCHEMBL19667229 0.74 PNMT (0.44) PNMTCHRNB2CHRNA4ADRA2AADRA2B
SCHEMBL19684585 0.74 CHRNB2 (0.41) PNMTCHRNB2CHRNA4ADRA2AADRA2B
SCHEMBL30406342 0.73 CYP11B2 (0.51) CYP11B2
SCHEMBL3947001 0.73 CYP11B2 (0.56) CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023105491-A1 5,6,7,8-TETRAHYDRO-2,6-NAPHTHYRIDINE DERIVATIVES AS CANCER THERAPEUTICS VRISE THERAPEUTICS, INC. (US) 2023-06-15 WO disclosed